Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by I. V. Fridman
Clinical Efficacy of Pneumococcal Conjugate 13-Valent Vaccine in Young Children
Pediatric pharmacology
Related publications
Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in an Isolated Pneumococcal Vaccine-Naïve Indigenous Population
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
PIN54 Cost-Effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared With 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Recommendations for the Prevention of Streptococcus Pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)
Pediatrics
Child Health
Pediatrics
Perinatology
Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in the Czech National Immunization Program
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Immunogenicity and Tolerance of a 7-Valent Pneumococcal Conjugate Vaccine in Nonresponders to the 23-Valent Pneumococcal Vaccine
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Public and Private Payer Perspectives on the Net Cost of Implementation of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Compared With 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Postlicensure Safety Surveillance for 7-Valent Pneumococcal Conjugate Vaccine
JAMA - Journal of the American Medical Association
Medicine
Effect of Use of 13-Valent Pneumococcal Conjugate Vaccine in Children on Invasive Pneumococcal Disease in Children and Adults in the USA: Analysis of Multisite, Population-Based Surveillance
The Lancet Infectious Diseases
Infectious Diseases
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR. Morbidity and mortality weekly report
Health Information Management
Mutagenesis
Epidemiology
Health
Medicine
Toxicology